STRIDES PHARMA SCIENCE Announces Quarterly Results (1QFY21); Net Profit Up 184.5%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES PHARMA SCIENCE Announces Quarterly Results (1QFY21); Net Profit Up 184.5%
Thu, 20 Aug

STRIDES PHARMA SCIENCE has announced its results for the quarter ended June 2020. Here is a detailed performance review of the same:

STRIDES PHARMA SCIENCE Quarterly Financials

No. of Mths
Qtr. Ending
3
Jun-19*
3
Mar-20*
3
Jun-20*
QoQ ChangeYoY Change
Net SalesRs m6,8586,1867,81826.4%14.0%
Other incomeRs m103177123-30.3%20.0%
TurnoverRs m6,9616,3637,94124.8%14.1%
ExpensesRs m5,6495,5366,26913.2%11.0%
Gross profitRs m1,143-1,0511,99874.9%
DepreciationRs m4294534918.4%14.6%
InterestRs m353403369-8.5%4.4%
Profit before taxRs m463-1,7311,261172.4%
TaxRs m31-105335.2%
Profit after taxRs m432-1,6261,228184.5%
Gross profit margin%16.7-17.025.6
Effective tax rate%6.76.02.6
Net profit margin%6.2-25.615.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 14.0% on a year-on-year (YoY) basis. The expenses were up by 11.0% YoY during the same period.
  • The company's operating profit increased by 74.9% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 25.6% in 1QFY21 as against 16.7% in 1QFY20.
  • Depreciation charges increased by 14.6% and finance costs increased by 4.4% YoY, respectively.
  • Other income increased by 20.0% YoY during the quarter.
  • Net profit for the quarter increased by 184.5% YoY. Net profit margins during the quarter increased from 6.2% in 1QFY20 to 15.5% in 1QFY21.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 26.4% on a quarter-on-quarter (QoQ) basis. The expenses were up by 13.2% QoQ during the same period.
  • The company's operating profit declined by 290.2% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 25.6% in 1QFY21 as against 17.0% in 4QFY20.
  • Net profit for the quarter increased by 175.5% QoQ, while net profit margins increased from -25.6% in 4QFY20 to 15.5% in 1QFY21.

To see how STRIDES PHARMA SCIENCE has performed over the last eight quarters,please visit here.

Mega Webinar on Jan 29th: Will 2021 be a boom or bust?

STRIDES PHARMA SCIENCE Share Price Performance

Over the last one year,STRIDES PHARMA SCIENCE share price has moved up from Rs 391.2 to Rs 570.1, registering a Gain of Rs 178.9 or around 45.7%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 19,124.3 (up 0.3%). Over the last one year it has moved up from 12,528.7 to 19,124.3, a gain of 6,596 points (up 52.6%).

Overall, the S&P BSE SENSEX is up 2.5% over the year.

Current Valuations

At the current price of Rs 570.1, the price to earnings (P/E) ratio of STRIDES PHARMA SCIENCE stands at 14.8 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 1.4 times.

Equitymaster requests your view! Post a comment on "STRIDES PHARMA SCIENCE Announces Quarterly Results (1QFY21); Net Profit Up 184.5%". Click here!

  

Related Views on News

STRIDES PHARMA SCIENCE Announces Quarterly Results (2QFY20); Net Profit Up 2778.7% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 2 bn (up 2778.7% YoY). Sales on the other hand came in at Rs 7 bn (down 2.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (1QFY20); Net Profit Up 1048.1% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 432 m (up 1048.1% YoY). Sales on the other hand came in at Rs 7 bn (up 3.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

More Views on News

Most Popular

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

Buzzing Sectors Before Budget 2021(Fast Profits Daily)

Jan 12, 2021

The budget is just a few weeks away. Which stocks can you expect to move? Find out in this video.

Here's Why Smallcaps Could Be Your Best Investment in 2021(Profit Hunter)

Jan 12, 2021

Select smallcaps hold a great potential to become the multibaggers of tomorrow. Here's how you could get in early into these stocks.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES PHARMA SCIENCE SHARE PRICE


Jan 25, 2021 01:26 PM

TRACK STRIDES PHARMA SCIENCE

  • Track your investment in STRIDES PHARMA SCIENCE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE 5-YR ANALYSIS

COMPARE STRIDES PHARMA SCIENCE WITH

MARKET STATS